Vol. 2 No. 2 (1996)
Case Report

Case Report: ANNA and the Diagnosis of Lung Cancer

PDF
  • T. Wein, M.D.,
  • C. Chalk, M.D.c.M., F.R.C.P. (C)
T. Wein, M.D.
McGil University
C. Chalk, M.D.c.M., F.R.C.P. (C)
McGill University
DOI: https://doi.org/10.26443/mjm.v2i2.709

Published 2020-12-01

Keywords

  • paraneoplastic sensory neuropathy,
  • ANNA-1

How to Cite

1.
Wein T, Chalk C. Case Report: ANNA and the Diagnosis of Lung Cancer. McGill J Med [Internet]. 2020 Dec. 1 [cited 2025 Oct. 7];2(2). Available from: https://mjm.mcgill.ca/article/view/709

Copyright (c) 1996 T. Wein, M.D., C. Chalk, M.D.c.M., F.R.C.P. (C)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Crossref
Scopus
Google Scholar
Europe PMC

Abstract

N/A

PDF

Downloads

Download data is not yet available.

References

  1. Mollmann JE. Cisplatin neurotoxicity. New England Journal of Medicine 322: 126-27; 1990.
  2. Schaumburg H, Kaplan J, Windebank A, et al. Sensory neuropathy from pyridoxine abuse: A new megavitamin syndrome. New England Journal of Medicine 309: 445-8; 1983.
  3. Griffin JW, Cornblath DR, Alexander E, et al. Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjogren's syndrome. Annals of Neurology 27: 304-15; 1990.
  4. Windebank AJ, Blexrud MD, Dyck PJ, et al. The syndrome of acute sensory neuropathy: Clinical features and electrophysiologic and pathologic changes. Neurology 40: 584-91; 1990.
  5. Dalakas MC. Chronic idiopathic ataxic neuropathy. Annals of Neurology 19: 545-54; 1986.
  6. Denny-Brown D. Primary sensory neuropathy with muscular changes associated with carcinoma. Journal of Neurology, Neurosurgery and Psychiatry 11: 73-87; 1948.
  7. Chalk CH, Windebank AJ, Kimmel DW, et al. The distinctive clinical features of paraneoplastic sensory neuronopathy. Canadian Journal of Neurological Science 19: 346-51; 1992.
  8. Chalk CH, Lennon VA, Stevens JC, et al. Seronegativity for type 1 antineuronal nuclear antibodies ("anti- Hu") in subacute sensory neuronopathy patients without cancer. Neurology 43: 2209-11; 1993.
  9. Kiers L, Altermatt HJ, Lennon VA. Paraneoplastic anti-neuronal nuclear IgG autoantibodies (type 1) localize antigen in small cell lung carcinoma. Mayo Clinic Proceedings 66: 1209-16; 1991.
  10. Graus F, Cordon-Cardo C, Posner JB. Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology 35: 538-43; 1985.
  11. Lennon VA. Calcium channel and related paraneoplastic disease autoantibodies. In: Peter JB, Shoenfeld Y, eds. Autoantibodies. Amsterdam: Elsevier Science B.V.; 1996: 139-147.
  12. Lucchinetti CF, Kimmel DW, Lennon VA. Clinical, oncological, and serological profiles of patients seropositive for type 1 anti-neuronal nuclear antibody (ANNA-1, a.k.a. "anti-Hu"). Neurology 44 (Suppl 2): A156.(abstract); 1994.
  13. Dalmau J, Graus F, Rosenblum MK, et al. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy: A clinical study of 71 patients. Medicine 71: 59-72; 1992.
  14. Sillevis Smitt PAE, Manley GT, Posner JB. Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice. Neurology 46: 1873-78; 1995.
  15. Peterson K, Rosenblum MK, Kotanides H, et al. Paraneoplastic cerebellar degeneration: I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 42: 1931-37; 1992.
  16. O'Neill JH, Murray NMF, Newsom-Davis J. The Lambert-Eaton syndrome: A review of 50 cases. Brain 111: 577-96; 1988.
  17. Anderson NE, Budde-Steffen C, Rosenblum MK, et al. Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: A distinct paraneoplastic syndrome. Medicine 67: 100-9; 1988.